Unadjusted and Multivariable-adjusted Odds of Having Chronic Kidney Disease for Specific Combinations of among Jackson Heart Study Participants at Baseline, 2000–2004.

OR, odds ratio; CI, confidence interval; HDL, high density lipoprotein.
AO, abdominal obesity; TRG, elevated triglycerides; EBP, elevated blood pressure; FBG, elevated fasting glucose; LHDL, Low high-density lipoprotein.
aAdjusted for age, gender, education, income, active living index, body mass index (BMI), cigarette smoking, and non-steroidal anti-inflammatory drugs (NSAIDs).
bP-values calculated using logistic regression.
abdominal obesity, defined by a waist circumference ≥102 cm in men and ≥88 cm in women; elevated blood pressure, defined as a systolic blood pressure of 130 mm Hg or greater and/or a diastolic blood pressure of 85 mm Hg or greater, physician diagnosis, and/or use of antihypertensive drugs; elevated plasma triglycerides (≥150 mg/dL) or treated dyslipidemia; low fasting HDL cholesterol (men <40 mg/dL and women <50 mg/dL; and elevated fasting glucose (≥100 mg/dL) or use of anti-diabetic medication.
Metabolic syndrome defined as having three or more of the following: abdominal obesity, elevated blood pressure, fasting blood glucose, triglycerides and low HDL cholesterol.

OR，比值比（odds ratio）；CI，置信区间（confidence interval）；HDL，高密度脂蛋白（high density lipoprotein）。
AO，腹型肥胖（abdominal obesity）；TRG，甘油三酯升高（elevated triglycerides）；EBP，血压升高（elevated blood pressure）；FBG，空腹血糖升高（elevated fasting glucose）；LHDL，低高密度脂蛋白（Low high-density lipoprotein）。
注a：校正混杂因素包括年龄、性别、教育程度、收入、活动生活指数、体质量指数（body mass index, BMI）、吸烟情况以及非甾体类抗炎药（non-steroidal anti-inflammatory drugs, NSAIDs）。
注b：P值通过logistic回归（logistic regression）计算得到。
腹型肥胖（abdominal obesity）定义为男性腰围≥102 cm、女性腰围≥88 cm；血压升高（elevated blood pressure）定义为收缩压≥130 mmHg且/或舒张压≥85 mmHg，或经医师诊断，或使用降压药物；血浆甘油三酯升高（elevated plasma triglycerides）定义为水平≥150 mg/dL，或接受调脂治疗的血脂异常；低空腹高密度脂蛋白胆固醇（low fasting HDL cholesterol）定义为男性<40 mg/dL、女性<50 mg/dL；空腹血糖升高（elevated fasting glucose）定义为水平≥100 mg/dL，或使用降糖药物。
代谢综合征（metabolic syndrome）定义为满足以下至少3项指标：腹型肥胖、血压升高、空腹血糖升高、甘油三酯升高以及低高密度脂蛋白胆固醇血症。